Cargando…
The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus
After the outbreak of SARS-CoV-2 by the end of 2019, the vaccine development strategies became a worldwide priority. Furthermore, the appearances of novel SARS-CoV-2 variants challenge researchers to develop new pharmacological or preventive strategies. However, vaccines still represent an efficient...
Autores principales: | García-Machorro, Jazmín, Ramírez-Salinas, Gema Lizbeth, Martinez-Archundia, Marlet, Correa-Basurto, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693616/ https://www.ncbi.nlm.nih.gov/pubmed/36366353 http://dx.doi.org/10.3390/vaccines10111844 |
Ejemplares similares
-
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020) -
In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
por: Ramírez Salinas, Gema Lizbeth, et al.
Publicado: (2023) -
Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies
por: Ramírez-Salinas, G. Lizbeth, et al.
Publicado: (2020) -
Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
por: Chi, L. América, et al.
Publicado: (2022) -
A Model for the Homotypic Interaction between Na(+),K(+)-ATPase β(1) Subunits Reveals the Role of Extracellular Residues 221–229 in Its Ig-Like Domain
por: Páez, Omar, et al.
Publicado: (2019)